|
Yu.A. Dolgikh, A.F. Verbovoy
Apelin: biological and pathophysiological effects
|
№11 / 2018
|
|
M.B. Antsiferov (1), A.V. Andreeva (1, 2)
Carcinoid syndrome in the practice of the endocrinologist
|
№11 / 2018
|
|
E.V. Biryukova
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
|
№11 / 2018
|
|
G.R. Galstyan (1), M.B. Antsiferov (2), Y.G. Alekseeva
Potentials for the management of cardiovascular risk in diabetic patients on insulin therapy
|
№11 / 2018
|
|
S.K. Zyryanov (1), M.Yu. Frolov (2, 3), M.V. Zhuravleva (4), V.A. Rogov (2), D.D. Sakaeva (5)
Pharmacoeconomic analysis of pembrolizumab in combination with chemotherapy as the first line of advances non-squamous non-small cell lung cancer treatment
|
№12 / 2018
|
|
I.G. Bakulin, I.A. Oganezova, O.I. Medvedeva, V.V. Petrenko, Yu.V. Medvedev
Multiple myeloma, secondary liver amiloidosis. Description of the clinical case
|
№12 / 2018
|
|
M.D. Budurova (1), M.R. Kanzapetov (1), M.M. Davydov (1), S.S. Gerasimov (1), V.A. Khaylenko (2)
Non-small cell lung cancer complicated by bleeding: a clinical case
|
№12 / 2018
|
|
I.A. Antyukhova, B.M. Medvedeva, A.B. Lukyanchenko
Difficulties of X-ray diagnostics of ectopic splenic tissue
|
№12 / 2018
|
|
T.E. Byalik
Venetoclax in clinical studies
|
№12 / 2018
|
|
G.S. Еmelyanova (1), N.F. Orel (2), A.S. Odintsova (1), V.A.Gorbunova (1)
Pharmacotherapy of neuroendocrine tumors
|
№12 / 2018
|
|
A.A. Markovich
Features of the clinical manifestations of nets. Carcinoid syndrome
|
№12 / 2018
|
|
A.E. Kuzminov, V.A. Gorbunova
Neuroendocrine tumors: general characteristics and features of management tactics
|
№12 / 2018
|
Русский
